3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis
Evaluation of 3D DL oZTEo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis
Mayo Clinic
25 participants
Dec 5, 2024
INTERVENTIONAL
Conditions
Summary
This project intends to explore and validate the utility of new MRI pulse sequence, 3D DL oZTEo, in the detection of osseous erosions of the hand in patients with inflammatory arthritis. The detection of osseous structural changes, such as erosive disease, is routinely assessed in patients with rheumatic conditions such as rheumatoid arthritis, as it alters clinical management, and in some cases assists in diagnosis. Currently, this is most often assessed with radiography and conventional MRI.
Eligibility
Inclusion Criteria4
- Adult patients ≥18 years of age
- Hand radiographs performed within the past 3-6 months with imaging results available for analysis
- Hand radiographs confirm the presence of bony erosions
- Scheduled for a hand MRI as part of their routine clinical care at Mayo Clinic Rochester
Exclusion Criteria1
- \- Less than18 years of age
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
An FDA approved MRI pulse sequence, oZTEo, will be added to a standard of care MRI examination. The oZTEo pulse sequence will be anonymized and sent to GE Healthcare for the application of a deep learning algorithm, 3D DL.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06383585